Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ACADIA PHARMACEUTICALS INC | Financial_Report.xls |
| EX-32.1 - EX-32.1 - ACADIA PHARMACEUTICALS INC | d838665dex321.htm |
| EX-21.1 - EX-21.1 - ACADIA PHARMACEUTICALS INC | d838665dex211.htm |
| EX-31.2 - EX-31.2 - ACADIA PHARMACEUTICALS INC | d838665dex312.htm |
| EX-31.1 - EX-31.1 - ACADIA PHARMACEUTICALS INC | d838665dex311.htm |
| EX-10.28 - EX-10.28 - ACADIA PHARMACEUTICALS INC | d838665dex1028.htm |
| 10-K - 10-K - ACADIA PHARMACEUTICALS INC | d838665d10k.htm |
| EX-32.2 - EX-32.2 - ACADIA PHARMACEUTICALS INC | d838665dex322.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-171722, 333-185639, and 333-194273) and the Registration Statements on Form S-8 (Nos. 333-115956, 333-128290, 333-137557, 333-146398, 333-153346, 333-161057, 333-168667, 333-176212, 333-183151, 333-190400, and 333-197872) of ACADIA Pharmaceuticals Inc. of our report dated February 26, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
| /s/PricewaterhouseCoopers LLP |
| San Diego, California |
| February 26, 2015 |